![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 51, 36715-36721, December 17, 1999
,
,
From the
Department of Chemical Engineering and the
§ Department of Microbiology and Molecular Genetics,
UCLA, Los Angeles, California 90095
| |
ABSTRACT |
|---|
|
|
|---|
Archaeoglobus fulgidus, a
hyperthermophilic sulfate-reducing Archaeon, contains high
Fe3+-EDTA reductase activity in its soluble protein
fraction. The corresponding enzyme, which constitutes about 0.75% of
the soluble protein, was purified 175-fold to homogeneity. Based on
SDS-polyacrylamide gel electrophoresis, the ferric reductase consists
of a single subunit with a Mr of 18,000. The
Mr of the native enzyme was determined by size
exclusion chromatography to be 40,000 suggesting that the native ferric
reductase is a homodimer. The enzyme uses both NADH and NADPH as
electron donors to reduce Fe3+-EDTA. Other Fe3+
complexes and dichlorophenolindophenol serve as alternative electron acceptors, but uncomplexed Fe3+ is not utilized. The
purified enzyme strictly requires FMN or FAD as a catalytic
intermediate for Fe3+ reduction. Ferric reductase also
reduces FMN and FAD, but not riboflavin, with NAD(P)H which classifies
the enzyme as a NAD(P)H:flavin oxidoreductase. The enzyme exhibits a
temperature optimum of 88 °C. When incubated at 85 °C, the enzyme
activity half-life was 2 h. N-terminal sequence analysis of the
purified ferric reductase resulted in the identification of the
hypothetical gene, AF0830, of the A. fulgidus
genomic sequence. The A. fulgidus ferric reductase shares
amino acid sequence similarity with a family of NAD(P)H:FMN oxidoreductases but not with any ferric reductases suggesting that the
A. fulgidus ferric reductase is a novel enzyme.
Acquisition of iron for assimilation into cellular protein is a
universal trait of life. Iron, in its many inorganic and organic forms,
is the fourth most abundant element on earth (1). However, at
physiological pH and under aerobic conditions, iron forms hydroxides and oxyhydroxides at exceedingly low solubilities of 10 Assimilatory ferric reductase activities have been identified and
characterized in animals, plants, yeast, and bacteria. In general,
these enzymes are monomeric to homotetrameric with molecular weights
ranging from 26,000 to 69,000 per monomer. The majority of the
eukaryotic ferric reductases is membrane-bound and contains cytochrome
b as well as covalently or non-covalently bound flavin (6-9). In contrast, prokaryotic ferric reductases lack cytochromes and
bound flavin but require exogenous FMN for optimal activity (10).
Dissimilatory ferric reductases catalyze the reduction of
Fe3+ as the terminal electron acceptor in energy metabolism
(11). Iron-reducing organisms are found among the Gram-negative and Gram-positive genera of the Proteobacteria. They include the following: Shewanella putrifacience, strain GS-15, Geobacter
metallireducens, Geobacter sulfurreducens,
Desulfuromonas acetoxidans, Bacillus species,
Thermotoga maritima, and other isolated bacteria (12-14). Two cytochrome c-type proteins with metal reductase activity
were purified from G. sulfurreducens and D. acetoxidans. They also reduced complexed Fe3+ (15,
16). Both c-type cytochromes are located in the periplasm of
the respective bacterium. Recently, Vargas et al. (17)
reported iron-reducing activities in cell suspensions of certain
hyperthermophilic Archaea including Archaeoglobus fulgidus.
The authors (17) demonstrated that the Archaeon, Pyrobaculum
islandicum, is capable of utilizing Fe3+-citrate as
electron acceptor for growth.
Our knowledge about dissimilatory and assimilatory iron reduction in
Archaea is scarce. Since little is known about the metabolism of iron
by the Archaea, the purpose of this study was to investigate ferric
iron reduction in the Archaeon A. fulgidus. A. fulgidus is
an anaerobic, sulfate-reducing Archaeon first isolated from marine
thermal vents in Southern Italy (18). In this paper, we describe the
purification and characterization of a ferric reductase from this
extremely thermophilic Archaeon. The A. fulgidus enzyme is
the first reported ferric reductase isolated from an Archaeon.
Cell Growth Conditions--
A. fulgidus VC-16 (DSM
4304) was grown anaerobically with 10 mM sodium lactate and
30 mM sodium sulfate at 83 °C. The medium was prepared
according to published methods (18) with the following modifications:
the carbonate buffer system was replaced by 20 mM
PIPES,1 pH 7.0 (pH adjusted
at room temperature), and sodium acetate was omitted. Large scale
cultures were grown in 70-liter batches using a custom-built 100-liter
glass-lined steel fermentor (Pfaudler, Rochester, NY). The cells were
harvested in late log phase (24 h after inoculation) at an optical
density (OD660) of 0.5-0.6 by concentrating with an A/G
Technology hollow fiber unit (Needham, MA, nominal molecular weight
cut-off 500,000). The concentrated cells were then pelleted by
centrifugation for 20 min at 16,000 × g. Cell yields
were approximately 80 g wet weight per 70 liters of culture.
Purification of Ferric Reductase--
All purification
procedures were performed aerobically at room temperature unless
indicated otherwise. Frozen cells were resuspended in 150 ml of 50 mM Tricine/KOH, pH 7.5, 2 mM MgCl2,
2 mg DNase II. The cells were lysed by passing the cell suspension
twice through a French pressure cell (Amicon) at 10,000 pounds/square inch. The insoluble fraction was removed by centrifugation at 130,000 × g for 90 min. A part of the soluble fraction
(10 ml, 180 mg of protein) was loaded onto a 5-ml Q-Sepharose column
(Amersham Pharmacia Biotech) equilibrated with 20 mM PIPES,
pH 7.0. The column was washed with 25 ml of PIPES buffer containing 10 mM NaCl, and ferric reductase was eluted with PIPES buffer
containing 60 mM NaCl. The eluted protein was applied to a
5-ml Red-agarose affinity column (Sigma) equilibrated with 20 mM PIPES, pH 7.0. After washing the column with 25 ml of
the PIPES buffer containing 0.7 M NaCl, the ferric
reductase was eluted with 0.9 M NaCl in PIPES buffer.
Ammonium sulfate was added to the eluent to a concentration of 1.7 M, and the proteins were applied onto a 1-ml
butyl-Sepharose hydrophobic interaction column (Amersham Pharmacia
Biotech) equilibrated with PIPES buffer containing 1.7 M
(NH4)2SO4. The column was washed with buffer containing 1.25 M
(NH4)2SO4, and protein containing ferric reductase activity was eluted with buffer containing 1.15 M (NH4)2SO4. The
purified protein was stored either at 4 °C or at Ferric Reductase Assay--
The ferric reductase assay was
adapted from the procedure described by Berczi et al. (6).
The assay was performed anaerobically in stoppered quartz cuvettes at
85 °C. The assay mixture contained 50 mM sodium
phosphate buffer, pH 7.0, 0.25 mM Fe3+-EDTA, 5 µM flavin mononucleotide (FMN) or flavin adenine
dinucleotide (FAD), and 0.18-36 µg of protein. The reaction was
initiated by the addition of NADH or NADPH to a final concentration of
0.1 mM, and the oxidation of NADH or NADPH was monitored at
340 nm using a DU 640 spectrophotometer equipped with a high
performance temperature controller (Beckman). Electron acceptors other
than Fe3+-EDTA were used at a concentration of 0.25 mM. NAD(P)H:flavin oxidoreductase activity was measured
with 50 µM FMN or FAD, and Fe3+-EDTA was
omitted. One unit of activity is defined as 1 µmol of NAD(P)H
oxidized per min.
Characterization of the pH Optimum and Stability--
The pH
optimum of the ferric reductase enzyme was determined using the
following buffers: 50 mM piperazine at pH 6.0, 6.5, and
6.7, 50 mM sodium phosphate at pH 6.8, 7.0, 7.2, 7.4, and 50 mM Tricine at pH 7.9. The pH stability of ferric
reductase was determined by incubating the enzyme at room temperature
in the buffers listed above. Samples were taken after 1 and 24 h, and ferric reductase activity was determined.
Determination of the Temperature Optimum and Stability--
The
temperature optimum was determined by performing the ferric reductase
assay at the indicated temperatures. The temperature stability of the
purified enzyme was determined by incubating the enzyme in stoppered
serum vials at the indicated temperatures. Samples were removed at the
indicated times, and the activity was measured at 85 °C.
Protein Determination--
The protein concentration was
measured with the Bradford assay (Bio-Rad) using bovine serum albumin
as the standard.
Gel Electrophoresis--
Proteins were separated on 20%
homogenous polyacrylamide gels under denaturing conditions with the
Amersham Pharmacia Biotech Phastsystem. Prior to loading, the protein
samples were incubated in SDS gel-loading buffer for 30 min at
100 °C (19). Precast SDS-polyacrylamide gels were purchased from
Amersham Pharmacia Biotech.
Molecular Weight Determination--
The apparent molecular
weight of the purified, denatured ferric reductase was determined from
the mobility of the protein in SDS-PAGE. The molecular weight standards
were bovine albumin (Mr 66,000), chicken egg
albumin (Mr 45,000), glyceraldehyde-3-phosphate dehydrogenase (Mr 36,000), bovine carbonic
anhydrase (Mr 29,000), bovine pancreas
trypsinogen (Mr 24,000), soybean trypsin
inhibitor (Mr 20,000), and bovine milk
N-terminal Amino Acid Sequence Analysis--
The purified
protein was run on a 20% polyacrylamide SDS gel and transferred to a
Sequi-Blot polyvinylidene difluoride membrane (Bio-Rad). The N-terminal
sequence analysis was performed by the Protein Microsequencing Facility
at UCLA.
Redox Titration of Complexed Fe3+--
The redox
potentials of Fe3+-EDTA, Fe3+-NTA, and
Fe3+-Citrate were determined with an Omni 90 potentiostat
set to cycle the voltage at 50 mV/s (Cypress Systems Inc.). The
potentiostat was equipped with an Ag/AgCl2 reference
electrode, a platinum auxiliary electrode, and a gold working
electrode. Voltammetry was were performed under anaerobic conditions in
20 mM PIPES, pH 7.0. The Fe3+ complexes were at
a concentration of 0.4 mM.
Ferric Reductase Activity--
By using a modified ferric
reductase assay adapted to 85 °C, high ferric reductase activity was
detected in the soluble protein fraction of A. fulgidus
VC-16 grown on lactate as carbon and energy source and sulfate as the
electron acceptor. With NADPH as the electron donor and
Fe3+-EDTA as the electron acceptor, the enzyme activity in
the soluble fraction was determined to be 1 unit/mg protein. Addition
of synthetic FMN to the assay stimulated the activity in the soluble
fraction by 20-fold (i.e. 20 units/mg protein) (Table
I). In contrast, the purified protein
strictly required FMN as a catalytic intermediate for activity (see
below). All assay components were stable at 85 °C for the duration
of the assay (at least 2 min). The membrane fraction did not contain
any measurable ferric reductase activity (<0.05 units/mg). Cell
extract prepared from the hyperthermophilic Archaeon, Pyrobaculum
aerophilum, did not exhibit ferric reductase activity (data not
shown).
Purification of the Ferric Reductase--
Ferric reductase was
purified to homogeneity using Q-Sepharose ion exchange, Red-agarose
affinity, and butyl-Sepharose hydrophobic interaction chromatography
(Fig. 1 and Table I). After the final purification step, the enzyme had been enriched 175-fold with a yield
of 16%. Based on this yield, ferric reductase was calculated to
comprise about 0.75% of the total soluble A. fulgidus
protein (w/w). By using SDS-PAGE, it was determined that the purified ferric reductase consists of a single polypeptide with an apparent molecular weight of 18,000 (Fig. 1). The molecular weight of the native
enzyme was determined to be 40,000 by size exclusion chromatography, suggesting that ferric reductase exists as a homodimer (data not shown). After purification, ferric reductase did not display any significant absorption in the visible range indicating that
chromophores such as flavin, heme, and/or Fe-S centers were absent
(data not shown).
Flavin Dependence of Ferric Reductase--
During protein
purification, it was noted that ferric reductase activity was gradually
lost. When the soluble A. fulgidus protein was subjected to
a desalting column, the activity was almost abolished suggesting that a
low molecular weight compound was required to retain activity. A
yellow-colored fraction that had been eluted from the desalting column
in the column volume restored ferric reductase activity. This yellow
compound exhibited a visible absorption spectrum characteristic of
flavins (data not shown). The preparation was not further
characterized. Synthetic FMN, FAD, but not riboflavin, also restored
ferric reductase activity (Table II, data
for FAD and riboflavin not shown). Without added flavin, no activity
was observed demonstrating that purified ferric reduction was strictly
dependent on either FMN or FAD.
To examine whether flavin could serve as the electron acceptor in place
of Fe3+-EDTA, activity of the purified enzyme was measured
in the absence of Fe3+-EDTA using a 10-fold higher
concentration of FMN, FAD, or riboflavin than in the ferric reductase
assay (Table II and Table III). Both FMN
and FAD, but not riboflavin, served as electron acceptors with NADH or
NADPH as electron donors. Therefore, the ferric reductase also
functions as an NAD(P)H:flavin oxidoreductase similar to the ferric
reductases of Saccharomyces cerevisiae and Escherichia coli (7, 20-22). Fig. 2A
shows the reduction of FAD by ferric reductase with NADH as the
electron donor. In contrast, FAD remains oxidized in the presence of
Fe3+-EDTA consistent with the notion that FAD serves here
as an electron mediator (Fig. 2B). Unlike many bacterial
ferric reductases, the A. fulgidus enzyme does not require
Mg2+ for optimal activity (data not shown) (2, 3, 23).
Since the A. fulgidus ferric reductase lacked any associated
flavin, a reconstitution of the enzyme with flavin was attempted. Ferric reductase was incubated with 1 mM FMN for 10 min at
60 °C. After incubation, the enzyme was subjected to a desalting and
subsequently to an ion exchange chromatography column (i.e. Q-Sepharose). Whereas free FMN eluted in the total volume of the desalting column and did not bind to the Q-Sepharose column, the ferric
reductase enzyme emerged brightly yellow-colored from the void volume
of the desalting and the NaCl eluent of the Q-Sepharose column. This
result demonstrates that the ferric reductase could be reconstituted
with FMN. The FMN is, therefore, non-covalently bound to the enzyme.
Based on the extinction coefficient for free FMN (12.2 mM Kinetic Properties of the Ferric Reductase--
The kinetic
properties of the ferric reductase were determined at 85 °C and are
summarized in Table III. With Fe3+-EDTA as the electron
acceptor, the purified ferric reductase exhibited a slightly higher
affinity and Vmax for NADH than for NADPH as the
electron donor. Based on the molecular weight of the dimeric ferric
reductase deduced from the gene sequence (i.e. 37, 318, see
below) turnover numbers of 3069 and 2180 s Electron Acceptors of Ferric Reductase--
Ferric reductase also
exhibited activity with other complexes that contained Fe3+
as the electron acceptor (Table IV). The
highest activity was obtained with sodium ferricyanide; it was 2.5 times higher than the activity measured with Fe3+-EDTA.
Activities of 12% or less were obtained with other ferric complexes
such as Fe3+-NTA and Fe3+-citrate. With
dichlorophenolindophenol, an artificial electron acceptor of many
flavoproteins, ferric reductase activity was half that with
Fe3+-EDTA. All electron acceptors were reduced only when
catalytic amounts of FMN were present. No activity was obtained with
uncomplexed Fe3+, i.e. FeCl3 and
Fe(OH)3 (data not shown), with the menaquinone analog
dimethylnaphthoquinone or with Fe2+-EDTA (Table IV). The
latter compound served as a control to demonstrate that the
Fe3+ and not the EDTA part of the complex was reduced by
the enzyme. Finally, ferric reductase did not reduce EDTA-chelated
Ag+ and Cu2+ (data not shown).
pH and Temperature Optima and Stability of Ferric
Reductase--
The A. fulgidus ferric reductase exhibited a
pH optimum of 7.0 (Fig. 3). To ensure
that the decrease of enzyme activity seen below and above pH 7.0 was
not due to enzyme instability, ferric reductase was incubated in
buffers at the different pH values for 24 h. The enzyme activity
was unchanged under all conditions suggesting that the loss of activity
below and above the pH optimum is due to protonation and deprotonation
of active site residues.
Ferric reductase activity was highest at 88 °C (Fig.
4). This temperature is close to the
optimal growth temperature of A. fulgidus (i.e.
83 °C). To evaluate the enzyme's temperature stability, ferric
reductase was incubated at various temperatures, and its activity was
measured at 85 °C (Fig. 5). The enzyme
was highly stable at room temperature retaining more than 90% of its
activity over 4 weeks, but it denatured with a half-life of 4 min when incubated at 100 °C. At incubation temperatures of 65 and 85 °C the half-life was 6.5 and 2 h, respectively.
Amino Acid Sequence Analysis of the Ferric Reductase--
The 19 N-terminal amino acids of the A. fulgidus ferric reductase
were determined to be
Met-Asp-Val-Glu-Ala-Phe-Tyr-Lys-Ile-Ser-Tyr-Gly-Leu-Tyr-Ile-Val-Thr-Ser-Glu. The amino acid sequence was used to search the A. fulgidus
genomic sequence data base of The Institute for Genomic Research. A
100% match was found to a hypothetical protein encoded by the
predicted coding region AF0830 (24). The hypothetical protein contains 169 amino acids, which corresponds to a molecular weight of 18,659. This molecular weight is consistent with that of the purified enzyme as
determined by SDS-PAGE (Fig. 1). The gene product of AF0830 is thus
identified as a ferric reductase or, alternatively, as a NAD(P)H:flavin
oxidoreductase. The corresponding gene is designated fer for
ferric reductase. The enzyme has a theoretical isoelectric point of 5.84.
Various data bases were searched for similar proteins. However, no
homology existed to any known ferric reductase. Homology of the
A. fulgidus ferric reductase was found to members of a family of NAD(P)H:flavin oxidoreductases and to other hypothetical proteins from a variety of prokaryotic organisms (Fig.
6). The NAD(P)H:flavin oxidoreductase
family includes the HpaC proteins from E. coli,
Photorhabidus luminescence, Klebsiella pneumoniae (here called HpaH), and the E. coli NmoB protein all of
which are involved in oxidative cleavage of 4-hydroxyphenylacetate
(25-27). The C-terminal domain of the Chelatobacter
heintzii NtaB protein is involved in the hydroxylation of
nitrilotriacetate (28-30). Other family members are the
Pseudomonas sp. StyB protein involved in styrene
hydroxylation, as well as the Streptomyces pristinaespiralis SnaC protein and the ActVB proteins from Streptomyces
coelicolor and Streptomyces roseofulvus involved in the
synthesis of antibiotics (31-35). The sequence identity between these
proteins and the A. fulgidus ferric reductase extends to
about 26% with a similarity of 47%.
Visual inspection of the amino acid sequences of the A. fulgidus ferric reductase and related proteins shown in Fig. 6
revealed 3 short regions that appear to be significantly conserved.
These regions are now defined as regions I, II, and III. Region I
includes the amino acid residues 36-39, (T/S)XXP, of the
A. fulgidus ferric reductase, where X indicates a
variable amino acid residue. Regions II and III include amino acids
62-67, FX(L/I/V)X(L/I/V)L, and amino acids
124-128, G(T/D)HX(L/I/V) of the A. fulgidus
ferric reductase sequence, respectively. None of the regions is
homologous to any known flavin- or NAD-binding sites. However, these
regions might be involved in flavin and/or NAD coordination.
A. fulgidus, when grown on lactate and sulfate,
contained the enzyme, ferric reductase, in its soluble protein
fraction. The ferric reductase was purified to homogeneity and found to
be very abundant in A. fulgidus (0.75% of the soluble
fraction) suggesting that it may have an important function in the
A. fulgidus metabolism. The enzyme catalyzes the reduction
of Fe3+-EDTA and other Fe3+ complexes with NADH
or NADPH as the electron donors and requires the addition of free
flavin for maximal activity.
The ferric reductase from A. fulgidus exhibits its
highest activity at 88 °C, which is close to the temperature optimum
for growth. Other enzymes isolated from A. fulgidus,
i.e. the isocitrate dehydrogenase, the NADP-specific
glutamate dehydrogenase, and the L-malate dehydrogenase
exhibit an even higher temperature optimum for activity of 90 °C or
greater (36-38). The latter enzymes have been reported to be very
thermostable with a half-life of 80 min at 101 °C for the
L-malate dehydrogenase, and 140 min at 100 °C for the
NADP-dependent glutamate dehydrogenase (37, 38). In
contrast, the ferric reductase exhibits a half-life of 4 min at
100 °C and is thus more similar to the A. fulgidus
isocitrate dehydrogenase (36).
Ferric reductases have been described previously in eukarya and
bacteria. Almost all of these enzymes are involved in iron assimilation
metabolism. This work presents the first characterization of an
archaeal ferric reductase. The A. fulgidus ferric reductase lacks any prosthetic groups after purification but strictly requires free FMN or FAD for the reduction of complexed Fe3+. In
this respect, the A. fulgidus ferric reductase resembles the
assimilatory bacterial ferric reductase enzymes isolated from Rhodobacter sphaeroides, Neisseria gonorrhoeae,
and E. coli that also require free flavin for ferric
reduction. (23, 39, 40). In addition, the A. fulgidus enzyme
utilizes flavin as a substrate and thus functions also as
NAD(P)H:flavin oxidoreductase. Since it was possible to reconstitute
the A. fulgidus ferric reductase with FMN, this enzyme
clearly classifies as a flavoprotein, and we suggest that the
enzyme-bound flavin is involved in catalysis. This is substantiated by
the very high affinity of the purified enzyme for FMN (i.e.
0.3 µM). Therefore, for the reduction of free flavin by
NAD(P)H, Reactions 1-6 are postulated as follows:
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
17
to 10
18 M (1 µM being the
threshold concentration to support life) (2, 3). For this reason,
organisms acquire insoluble Fe3+ by complexing it with
ferric-specific chelators, i.e. siderophores (2). Depending
on the organism, the reduction of complexed Fe3+ is
accomplished either before or after transport into the cell. Ferric
reductase catalyzes the reduction of complexed Fe3+ to
complexed Fe2+ using NAD(P)H as the electron donor (4). The
resulting Fe2+ is subsequently released and
incorporated into iron-containing proteins (5).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C for long term.
-lactalbumin (Mr 14, 200) (Sigma). The
apparent molecular weight of the native ferric reductase was determined
by size exclusion chromatography with a Superose 6 column from Amersham
Pharmacia Biotech. The column was run in 50 mM PIPES, pH
7.0, 200 mM NaCl at a flow rate of 0.4 ml/min. The
following molecular weight markers from Amersham Pharmacia Biotech were
used: ribonuclease A (Mr 13, 700),
chymotrypsinogen A (Mr 25,000), ovalbumin
(Mr 43,000), and bovine serum albumin (Mr 67,000).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Purification of the ferric reductase from A. fulgidus

View larger version (53K):
[in a new window]
Fig. 1.
SDS-PAGE analysis of the purified A. fulgidus ferric reductase. Lane 1, 1 µg of
ferric reductase; lane 2, molecular weight markers (see
under "Experimental Procedures").
FMN dependence of purified ferric reductase activity from A. fulgidus
determined with NADPH as the electron donor
Kinetic properties of the ferric reductase from A. fulgidus

View larger version (14K):
[in a new window]
Fig. 2.
Absorption spectrum of FAD reduction with
NADH by purified ferric reductase (FeR) in the absence
(A) and presence of 200 µM
Fe3+-EDTA (B). The reaction buffer
contained 50 mM
NaH2PO4-Na2HPO4, pH
7.0, 100 µM NADH, and 40 µM FAD. Spectra
were recorded after anaerobic incubation for 5 min at 80 °C without
(
FeR) and with ferric reductase (0.25 µg)
(+FeR).
1 cm
1 at 450 nm) the amount
of FMN per monomer was determined to be 1.4 mol/mol.
1 for NADH and
NADPH oxidation, respectively, were calculated. The
Km for FMN as catalytic intermediate in ferric iron reduction and as electron acceptor in place of Fe3+-EDTA
were identical (data not shown) and more than 200-fold lower than that
for Fe3+-EDTA (Table III). The Vmax
values with FMN and FAD were about 12-fold slower than that determined
with Fe3+-EDTA. The corresponding turnover numbers were 174 s
1 for FMN reduction and 216 s
1 for FAD reduction.
Substrate specificity for various electron acceptors of the ferric
reductase from A. fulgidus

View larger version (12K):
[in a new window]
Fig. 3.
pH dependence of the A. fulgidus
ferric reductase activity. The activity was measured as
described under "Experimental Procedures."

View larger version (16K):
[in a new window]
Fig. 4.
Temperature dependence of the A. fulgidus ferric reductase activity. The activity was
measured at 85 °C as described under "Experimental
Procedures."

View larger version (17K):
[in a new window]
Fig. 5.
Thermal stability of the A. fulgidus ferric reductase. The enzyme was incubated at
the temperatures indicated in the figure. At various times samples were
withdrawn, and ferric reductase activity was measured at 85 °C as
described under "Experimental Procedures."

View larger version (101K):
[in a new window]
Fig. 6.
Multiple sequence alignment of A. fulgidus ferric reductase-related proteins generated by
pileup and edited by GeneDoc. Consensus residues are indicated by
white letters on black background for 100% homology and
white letters on gray background for 80% homology.
Bars above the sequence indicated the location of the
conserved regions I, II, and III. Abbreviations and accession numbers
for proteins are as follows: Af.FeR, A. fulgidus ferric
reductase (gi 2649784); Ph.Ph0856, Pyrococcus horikoshii
hypothetical protein (gi 3257267); Af.AF1786, A. fulgidus
hypothetical protein (gi 2648759); Sc.Orf1, Synechococcus
sp. (strain PCC 7942) hypothetical protein (gi 310858); Ss.Slr0001,
Synechocystis sp. (strain PCC 6803) hypothetical protein
(gi 1001553); Ss.Sll0550, Synechocystis sp. (strain PCC
6803) putative flavodoxin (gi 1001242); Kp.HpaH, K. pneumoniae coupling protein (gi 974147); Ec.HpaC, E. coli component C of the 4- hydroxyphenylacetate-hydroxylase
(gi 757835); Pl.HpaC, Photorhabdus luminescens
4-hydroxyphenylacetic acid hydroxylase putative coupling protein
(gi 3002549); Ec.NmoB, E. coli 4-hydroxyphenylacetate
3-monooxygenase small chain (gi 4062570); Mt.Rv3567c, M. tuberculosis hypothetical nitrilotriacetate monooxygenase
component B (gi 1877298); Re.DszD, Rhodococcus erythropolis
NADH:FMN oxidoreductase (gi 2944380); Ch.NtaB, C. heintzii
nitrilotriacetate monooxygenase component B (gi 2507085); Rp.RP149,
Rickettsia prowazekii hypothetical protein (gi 3860716);
Stc.ActVB, S. coelicolor actinorhodin polyketide dimerize
(gi 2498304); Str.ActVB, S. roseofulvus ActVB homolog
(gi 3170573); Stp.SnaC, S. pristinaespiralis NADH:FMN
oxidoreductase (gi 1711412); Stv.GraOrf Streptomyces
violaceoruber putative FMN:NADH oxidoreductase (gi 4218572);
Ps.StyB, P. fluorescens StyB protein (gi 2154928).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Since the affinity for FMN is significantly higher
(i.e. 220-fold) than for Fe3+-EDTA, it is likely
that enzyme-bound flavin is also involved in the catalysis of
Fe3+-EDTA reduction, which is described by Reactions
4-6.
or
The different kcat values for flavin
versus ferric reduction can be explained by Reaction 3 being
rate-limiting for flavin reduction, whereas Reactions 4 and 5 (or 6)
are much faster than Reaction 3 and rate-determining for the ferric
reductase activity.
Whereas the affinities for NAD(P)H, Fe3+ complexes, and FMN among the bacterial ferric reductases and the archaeal enzyme are similar, the A. fulgidus enzyme differs strikingly by its very high specific activity. The activity of the A. fulgidus enzyme is at least 1000-fold higher than all other bacterial ferric reductase activities that have been measured thus far (Table I), and it is 40 times more active than the fastest eukaryotic ferric reductase isolated from spinach (6). Enzymes from extremeophiles usually exhibit enzyme activities that are in the same range as their mesophilic counter parts. Examples for thermophilic enzymes from A. fulgidus that have specific activities like their mesophilic counter parts include the isocitrate, L-malate, and NADP-dependent glutamate dehydrogenases (36, 37, 38).
E. coli contains three distinct enzymes that serve as assimilatory ferric reductases (42). Like the major ferric reductase in E. coli, the A. fulgidus enzyme also functions as an NAD (P)H: flavin oxidoreductase (see above) (42). However, the A. fulgidus enzyme has a specific activity more than 750-fold higher than the major E. coli flavin reductase, Fre. Whereas the A. fulgidus enzyme also utilizes FAD and FMN as electron acceptors, riboflavin does not serve as a substrate. This is unlike the E. coli major NAD(P)H:flavin oxidoreductase, which reduces FMN, FAD, and riboflavin (20). This NAD(P)H:flavin oxidoreductase has been demonstrated to activate ribonucleotide reductase in E. coli by reducing the enzyme's [Fe-S] center, which subsequently generates a tyrosyl radical (39). Coves and Fontecave (20) suggested that the reduced flavin produced by the E. coli NAD(P)H:flavin oxidoreductase serves to reduce chemically several suitable electron acceptors. It is, therefore, feasible that the A. fulgidus ferric reductase may also have a dual function in the metabolism of A. fulgidus.
N-terminal amino acid sequence analysis of the purified ferric reductase resulted in the identification of a hypothetical protein in A. fulgidus with no previously known function (i.e. encoded by gene AF0830). This protein is now assigned the function of a ferric reductase and an NAD(P)H:flavin oxido- reductase. Interestingly, no homology was found between the A. fulgidus ferric reductase and the ferric reductases from S. cerevisiae or from E. coli (21, 22). However, significant homology of the A. fulgidus ferric reductase exists to a family of NAD(P)H:flavin oxidoreductases that are members of a two-enzyme system, in which the NAD(P)H:flavin oxidoreductase generates reduced FMN for a monooxygenase (Fig. 6). In general, these monooxygenases are involved in the oxidative degradation of aromatic compounds, hydrocarbons, or in polyketide biosynthesis. Although the deduced amino acid sequence for the A. fulgidus ferric reductase did not reveal any known motif conclusive for the coordination of a prosthetic group, three conserved regions were noted (Fig. 6). These regions may be involved in the coordination of flavin and/or NAD. The three regions noted in this study are also present in the C-terminal domains of 4 Synechocystis sp. A-type flavoproteins of unknown function (43). The latter proteins contain a partially conserved flavodoxin signature within their N-terminal domain, which is speculated to be responsible for the binding of FMN. One of the Synechocystis flavoproteins was demonstrated to bind both FAD and FMN (43); however, it is not known whether this flavoprotein interacts with NADH or Fe3+.
The A. fulgidus ferric reductase is distinct from the dissimilatory cytochrome c-type metal reductases isolated from the iron-reducing bacteria D. acetoxidans and G. sulfurreducens (15, 16). These proteins have broad substrate specificity for complexed and uncomplexed Fe3+ compounds, manganese dioxide, elemental S0, and other compounds. In contrast, the A. fulgidus ferric reductase does not use uncomplexed iron and has its highest specificity for Fe3+-EDTA, although the redox potentials for Fe3+/Fe2+-NTA and Fe3+/Fe2+-citrate are almost identical to that of Fe3+/Fe2+-EDTA (Table IV).
The physiological role of ferric reductase in the sulfate-reducing
A. fulgidus is uncertain. Functionally, the enzyme is more similar to the assimilatory ferric reductases. However, because of its
high cellular abundance (see above), it seems possible that this enzyme
serves a dissimilatory rather than an assimilatory function. Vargas
et al. (17) previously reported on ferric reductase activity
in A. fulgidus. In their study, the activity was measured with cell suspensions using hydrogen as the electron donor and Fe3+-citrate as the electron acceptor. The authors
concluded that this reaction could potentially be used to generate
energy for growth, although growth of A. fulgidus with
Fe3+-citrate was not demonstrated. The ferric reductase
purified in this study could be the key enzyme of this possible
electron transfer pathway since the purification yielded only one type
of this enzyme. A speculative electron transfer chain could contain a
hydrogenase that oxidizes hydrogen to protons on the outside of the
cell. The electrons could be transferred across the cytoplasmic
membrane to an NADH dehydrogenase that would consume protons on the
cytoplasmic side to generate NADH. NADH would then be regenerated by
the cytoplasmically located ferric reductase. The scalar proton
translocation would be sufficient to generate the proton motive force.
This electron transfer pathway resembles somewhat the sulfate reduction
pathway, which also involves soluble terminal reductases,
i.e. the APS reductase and the sulfite reductase (44-46).
Whether an electron transport chain involving the ferric reductase
characterized in this study exists in A. fulgidus still has
to be established.
| |
ACKNOWLEDGEMENT |
|---|
We thank the anonymous reviewer of this manuscript for the helpful suggestions regarding the flavin reconstitution and the flavin and ferric reduction mechanism, which greatly strengthened our manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant HL-16251 and National Sciennce Foundation Grant MCB-9631006 (to I. S.) and a grant from the United States Department of Commerce/NIST Cooperative Research Agreement No. 70NANB7H0009 (to H. G. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, 1602 Molecular Sciences Bldg., UCLA, Los Angeles, CA 90095. Tel.: 310-825-8085; Fax: 310-206-5231; E-mail: imkes@microbio.ucla.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PIPES, 1,4-piperazinediethanesulfonic acid; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; PAGE, polyacrylamide gel electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Briat, J. F. (1992) J. Gen. Microbiol. 138, 2475-2483[Medline] [Order article via Infotrieve] |
| 2. |
Huyer, M.,
and Page, W. J.
(1989)
J. Bacteriol.
171,
4031-4037 |
| 3. | Barchini, E., and Cowart, R. E. (1996) Arch. Microbiol. 166, 51-57[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Lesuisse, E., Crichton, R. R., and Labbe, P. (1990) Biochim. Biophys. Acta 1038, 253-259[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Guerinot, M. L. (1994) Annu. Rev. Microbiol. 48, 743-772[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Berczi, A., Fredlund, K. M., and Moller, I. M. (1995) Arch. Biochem. Biophys. 320, 65-72[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Shatwell, K. P.,
Dancis, A.,
Cross, A. R.,
Klausner, R. D.,
and Segal, A. W.
(1996)
J. Biol. Chem.
271,
14240-14244 |
| 8. | Sparla, F., Bagnaresi, P., Scagliarini, S., and Trost, P. (1997) FEBS Lett. 414, 571-575[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Bruggemann, W., Moog, P. R., Nakagawa, H., Janiesch, P., and Kuiper, P. J. C. (1990) Physiol. Plant. 79, 339-346[CrossRef] |
| 10. | Fonteclave, M., Coves, J., and Pierre, J.-L. (1994) Biometals 7, 3-8[Medline] [Order article via Infotrieve] |
| 11. | Gorby, Y. A., and Lovley, D. R. (1991) Appl. Environ. Microbiol. 1991, 867-870 |
| 12. |
Caccavo, F., Jr.,
Lonergan, D. J.,
Lovley, D. R.,
Davis, M.,
Stolz, J. F.,
and McInerney, M. J.
(1994)
Appl. Environment. Microbiol.
60,
3752-3759 |
| 13. | Lovley, D. R. (1993) Annu. Rev. Microbiol. 47, 263-290[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Slobodkin, A., Reysenbach, A. L., Strutz, N., Dreier, M., and Wiegel, J. (1997) Int. J. Syst. Bacteriol. 47, 541-547[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Aubert, C.,
Lojou, E.,
Bianco, P.,
Rousset, M.,
Durand, M.-C.,
Bruschi, M.,
and Dolla, A.
(1998)
Appl. Environ. Microbiol.
64,
1308-1312 |
| 16. |
Seeliger, S.,
Cord-Ruwisch, R.,
and Schink, B.
(1998)
J. Bacteriol.
180,
3686-3691 |
| 17. | Vargas, M., Kashefi, K., Blunt-Harris, E. L., and Lovley, D. (1998) Nature 395, 65-67 |
| 18. | Zellner, G., Stackebrandt, E., Kneifel, H., Messner, P., Sleytr, U. B., De Marcario, E. C., Zabel, H.-P., Stetter, K. O., and Winter, J. (1989) Syst. Appl. Microbiol. 11, 151-160 |
| 19. |
Schröder, I.,
Wolin, C. D.,
Cavicchioli, R.,
and Gunsalus, R. P.
(1994)
J. Bacteriol.
176,
4985-4992 |
| 20. | Coves, J., and Fontecave, M. (1993) Eur. J. Biochem. 211, 635-641[Medline] [Order article via Infotrieve] |
| 21. |
Dancis, A.,
Roman, D. G.,
Anderson, G. J.,
Hinnebusch, A. G.,
and Klauser, R. D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
3869-3873 |
| 22. |
Spyrou, G.,
Haggard-Ljungquist, E.,
Krook, M.,
Jornval, H.,
Nilsson, E.,
and Reichard, P.
(1991)
J. Bacteriol.
173,
3673-3679 |
| 23. | Le Faou, A. E., and Morse, S. A. (1991) Biol. Met. 4, 126-131[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Klenk, H. P., Clayton, R. A., Tomb, J. F., White, O., Nelson, K. E., Ketchum, K. A., Dodson, R. J., Gwinn, M., Hickey, E. K., Peterson, J. D., Richardson, D. L., Kerlavage, A. R., Graham, D. E., Kyrpides, N. C., Fleischmann, R. D., Quackenbush, J., Lee, N. H., Sutton, G. G., Gill, S., Kirkness, E. F., Dougherty, B. A., McKenney, K., Adams, M. D., Loftus, B., Peterson, S., Reich, C. I., McNeil, L. K., Badger, J. H., Glodek, A., Zhou, L., Overbeek, R., Gocayne, J. D., Weidman, J. F., McDonald, L., Utterback, T., Cotton, M. D., Spriggs, T., Artiach, P., Kaine, B. P., Sykes, S. M., Sadow, P. W., D'Andrea, K. P., Bowman, C., Fujii, C., Garland, S. A., Mason, T. M., Olsen, G. J., Fraser, C. M., Smith, H. O., Woese, C. R., and Venter, J. C. (1997) Nature 390, 364-370[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Prieto, M. A.,
Diaz, E.,
and Garcia, J. L.
(1996)
J. Bacteriol.
178,
111-120 |
| 26. | Gibello, A., Suarez, M., Allende, J. L., and Martin, M. (1997) Arch. Microbiol. 167, 160-166[CrossRef] |
| 27. | Aiba, H., Baba, T., Fujita, K., Hayashi, K., Honjo, A., Horiuchi, T., Ikemoto, K., Inada, T., Isono, K., Isono, S., Itoh, T., Kanai, K., Kasai, H., Kashimoto, K., Kim, S., Kimura, S., Kitagawa, M., Kitakawa, M., Makino, K., Masuda, S., Miki, T., Mizobuchi, K., Mori, H., Motomura, K., Nakamura, Y., Nashimoto, H., Nishio, Y., Oshima, T., Saito, N., Sampei, G., Seki, Y., Tagami, H., Takemoto, K., Wada, C., Yamamoto, Y., and Yaro, M. (1996) DNA Res. 3, 137-155[Abstract] |
| 28. |
Uetz, T.,
Schneider, R.,
Snozzi, M.,
and Egli, T.
(1992)
J. Bacteriol.
174,
1179-1188 |
| 29. |
Knobel, H. R.,
Egli, T.,
and van der Meer, J. R.
(1996)
J. Bacteriol.
178,
6123-6132 |
| 30. |
Xu, Y.,
Mortimer, M. W.,
Fisher, T. S.,
Kahn, M. L.,
Brockman, F. J.,
and Xun, L.
(1997)
J. Bacteriol.
179,
1112-1116 |
| 31. | Beltrametti, F., Marconi, A. M., Bestetti, G., Colombo, C., Galli, E., and Ruzzi, M. a. Z., E. (1997) Appl. Environ. Microbiol. 63, 2232-2239[Abstract] |
| 32. |
Blanc, V.,
Lagneaux, D.,
Didier, P.,
Gil, P.,
Lacroix, P.,
and Crouzet, J.
(1995)
J. Bacteriol.
177,
5206-5214 |
| 33. |
Fernandez-Moreno, M. A.,
Martinez, E.,
Boto, L.,
Hopwood, D. A.,
and Malpartida, F.
(1992)
J. Biol. Chem.
267,
19278-19290 |
| 34. |
Kendrew, S. G.,
Harding, S. E.,
Hopwood, D. A.,
and Marsh, E. N. G.
(1995)
J. Biol. Chem.
270,
17339-17343 |
| 35. | Bibb, M. J., Sherman, D. H., Omura, S., and Hopwood, D. A. (1994) Gene (Amst.) 142, 31-39[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Steen, I. H., Lien, T., and Birkeland, N.-K. (1997) Arch. Microbiol. 168, 412-420[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Aalen, N., Steen, I. H., Birkeland, N.-K., and Lien, T. (1997) Arch. Microbiol. 168, 536-539[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Langelandsvik, A. S., Steen, I. H., Birkeland, N.-K., and Lien, T. (1997) Arch. Microbiol. 168, 59-67[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Fonteclave, M.,
Eliasson, R.,
and Reichard, P.
(1987)
J. Biol. Chem.
262,
12325-12331 |
| 40. |
Moody, M. D.,
and Dailey, H. A.
(1985)
J. Bacteriol.
163,
1120-1125 |
| 41. | Deleted in proof |
| 42. | Eschenbrenner, M., Coves, J., and Fontecave, M. (1994) Biochem. Biophys. Res. Commun. 198, 127-131[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Wasserfallen, A., Ragettli, S., Jouanneau, Y., and Leisinger, T. (1998) Eur. J. Biochem. 254, 325-332[Medline] [Order article via Infotrieve] |
| 44. | Odom, J. M., and Peck, H. D. (1984) Annu. Rev. Microbiol. 38, 551-592[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Speich, N., and Trueper, H. G. (1988) J. Gen. Microbiol. 134, 1419-1425 |
| 46. | Dahl, C., Kredrich, N. M., Deutzmann, R., and Trueper, H. G. (1993) J. Gen. Microbiol. 139, 1817-1828[Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
R. Zarnowski and J. P. Woods Glutathione-dependent extracellular ferric reductase activities in dimorphic zoopathogenic fungi Microbiology, July 1, 2005; 151(7): 2233 - 2240. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schroder, A. Vadas, E. Johnson, S. Lim, and H. G. Monbouquette A Novel Archaeal Alanine Dehydrogenase Homologous to Ornithine Cyclodeaminase and {micro}-Crystallin J. Bacteriol., November 15, 2004; 186(22): 7680 - 7689. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. H. van den Heuvel, A. H. Westphal, A. J. R. Heck, M. A. Walsh, S. Rovida, W. J. H. van Berkel, and A. Mattevi Structural Studies on Flavin Reductase PheA2 Reveal Binding of NAD in an Unusual Folded Conformation and Support Novel Mechanism of Action J. Biol. Chem., March 26, 2004; 279(13): 12860 - 12867. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kirchner, A. H. Westphal, R. Muller, and W. J. H. van Berkel Phenol Hydroxylase from Bacillus thermoglucosidasius A7, a Two-protein Component Monooxygenase with a Dual Role for FAD J. Biol. Chem., November 28, 2003; 278(48): 47545 - 47553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Filisetti, M. Fontecave, and V. Niviere Mechanism and Substrate Specificity of the Flavin Reductase ActVB from Streptomyces coelicolor J. Biol. Chem., January 3, 2003; 278(1): 296 - 303. [Abstract] [Full Text] [PDF] |
||||